BRCA Founder OutReach (BFOR) Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
BRCA Founder OutReach (BFOR) Study	BRCA1 Mutation; BRCA2 Mutation	Active, not recruiting	Not stated	2026-05-28		NCT03351803

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beth Israel Deaconess Medical Center	161
Breast Cancer Research Foundation	40
Brigham and Women's Hospital	378
Dana-Farber Cancer Institute	324
LIFELINK.COM INC	1
Memorial Sloan Kettering Cancer Center	753
Quest Diagnostics-Nichols Insitute	5
University of California, Los Angeles	355
University of Pennsylvania	502

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beth Israel Deaconess Medical Center	Boston	United States	462
Dana Farber Cancer Institute	Boston	United States	133
Memorial Sloan - Kettering Cancer Center	New York	United States	8
University of California, Los Angeles	Los Angeles	United States	142
University of Pennsylvania	Philadelphia	United States	4